What This Document Is
This document consists of ATI flash cards focused on medications affecting the endocrine system, specifically those used in the management of diabetes. It’s designed as a rapid-review tool for nursing students, presenting key information about various drug classes – including insulin, oral hypoglycemics like sulfonylureas, meglitinides, biguanides, thiazolidinediones, and alpha-glucosidase inhibitors – in a concise, question-and-answer format. The cards cover expected actions, therapeutic uses, adverse effects, contraindications, precautions, interactions, and essential patient education points.
Why This Document Matters
This resource is valuable for Keiser University Pharmacology (NUR 1140C) students preparing for exams or clinical rotations. It’s particularly helpful for quickly memorizing drug profiles and understanding crucial nursing considerations related to endocrine medications. It serves as a focused study aid to reinforce concepts learned in lectures and textbooks, helping students confidently apply their knowledge in patient care scenarios. It’s most useful when used *in conjunction* with a comprehensive pharmacology curriculum.
Common Limitations or Challenges
This flash card set is a condensed review and does *not* provide in-depth explanations of the underlying pathophysiology of endocrine disorders or the detailed mechanisms of action of each drug. It’s a memory aid, not a substitute for thorough learning. Users will still need to consult textbooks, lecture notes, and other resources for a complete understanding. This preview does not include all cards from the full set.
What This Document Provides
The full set of flashcards includes:
* Key information on different types of insulin (Lispro, Aspart, Glargine, NPH, Regular) – duration, onset, and administration.
* Profiles of oral hypoglycemic agents – including Meglitinides, Sulfonylureas, Biguanides, Thiazolidinediones, and Acarbose – covering adverse effects, contraindications, and patient education.
* Important nursing considerations, such as mixing insulin types, monitoring blood glucose levels, and recognizing potential drug interactions.
* Guideline ranges for pre- and postprandial glucose levels and HbA1c targets.
This preview only provides a sample of the content, focusing on insulin and a few oral hypoglycemic agents. The complete document contains a more extensive range of medications and detailed information.
